1-4 of 4
Eva-Maria Reitter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Firstline Daratumumab Shows High Hematologic and Organ Response Rates in Advanced Cardiac AL Amyloidosis - a Retrospective Case Series

Georg Jeryczynski, MD, Antonia Eder, Eva-Maria Reitter, MD, Maria-Theresa Krauth, MD, Hermine Agis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3123.
https://doi.org/10.1182/blood-2019-124681
Published: 2019
Journal Articles

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Florian Posch, MD MSc, Julia Riedl, MD, Eva-Maria Reitter, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1095.
https://doi.org/10.1182/blood.V130.Suppl_1.1095.1095
Published: 2017
Journal Articles

Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality

Julia Riedl, Florian Posch, Eva-Maria Reitter, Ernst Eigenbauer, Christine Marosi, Ilse Schwarzinger, Christoph Zielinski, Ingrid Pabinger, Cihan Ay, MD
Journal: Blood
Blood (2014) 124 (21): 2859.
https://doi.org/10.1182/blood.V124.21.2859.2859
Published: 2014
Journal Articles

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

Ingrid Pabinger, MD, Cihan Ay, MD, Daniela Dunkler, Johannes Thaler, Eva-Maria Reitter, Christine Marosi, Christoph Zielinski, Christine Mannhalter
Journal: Blood
Blood (2012) 120 (21): 2253.
https://doi.org/10.1182/blood.V120.21.2253.2253
Published: 2012